Developer of precision medicine in oncology designed to provide big data analysis in cancer. The company develops a cell-free liquid biopsy technology, enabling healthcare professionals to use minimally-invasive molecular diagnosis for treatment selection, therapy monitoring, and detection of cancer earlier.
We design and develop a novel class of immunotherapy antibodies combining the precision of immune checkpoint modulators with the long-term impact of vaccines.
